Aim: To evaluate outcomes of laparoscopic adrenalectomy (LA) and laparoendoscopic single-site surgery (LESS) for adrenal masses in the light of changing laparoscopic surgical techniques. Materials and Methods: Seventy-three patients were analyzed retrospectively. There were 2 groups; group 1 included patients who had conventional transperitoneal LA and transperitoneal LESS, and group 2 included patients who had lateral retroperitoneal LA, retroperitoneal LA in prone position, and retroperitoneal LESS. Demographic data, urine 3-methoxy-4-hydroxymandelic acid, normetanephrine, epinephrine, serum cortisol, aldosterone, adrenocorticotropic hormone, American Society of Anesthesiologists score, side and size of mass, conversion to open surgery, complications, estimated blood loss, operation time, pathological results were recorded and analyzed. Results: There was no difference in demographic data and serum parameters between both groups. Tumor size, estimated blood loss, operation time, transfusion rate and hospital stay were less for group 2 (p < 0.05, p = 0.0001). However, the complication rate was similar in both groups; in retroperitoneal prone position, the complication rate was less than for other surgical approaches, but statistically significant results could not be assessed. Conclusions: Even if the diameter of adrenal mass is larger than 6 cm, LA may be considered as the gold standard. The retroperitoneal approach especially in prone position may be a promising treatment method in the near future for adrenalectomy in selected patients.

Keywords:
Adrenal gland, Adrenalectomy, Laparoscopy, Laparoendoscopic single-site surgery, Surgical techniques
1.
Ramacciato G, Mercantini P, La Torre M, Di Benedetto F, Ercolani G, Ravaioli M, Piccoli M, Melotti G: Is laparoscopic adrenalectomy safe and effective for adrenal masses larger than 7 cm? Surg Endosc 2008;22:516-521.
2.
Gagner M, Lacroix A, Bolté E: Laparoscopic adrenalectomy in Cushing's syndrome and pheochromocytoma. N Engl J Med 1992;327:1033.
3.
Choi SH, Hwang HK, Kang CM, Lee WJ: Transumbilical single port laparoscopic adrenalectomy: a technical report on right and left adrenalectomy using the glove port. Yonsei Med J 2012;53:442-445.
4.
Chung SD, Huang CY, Wang SM, Tai HC, Tsai YC, Chueh SC: Laparoendoscopic single-site (LESS) retroperitoneal adrenalectomy using a home made single-access platform and standard laparoscopic instruments. Surg Endosc 2011;25:1251-1256.
5.
Winfield HN, Hamilton BD, Bravo EL, Novick AC: Laparoscopic adrenalectomy: the preferred choice? A comparison to open adrenalectomy. J Urol 1998;160:325-329.
6.
Castellucci SA, Curcillo PG, Ginsberg PC, Saba SC, Jaffe JS, Harmon JD: Single port access adrenalectomy. J Endourol 2008;22:1573-1576.
7.
Sung GT, Hsu TH, Gill IS: Retroperitoneoscopic adrenalectomy: lateral approach. J Endourol 2001;15:505-511.
8.
Berber E, Tellioglu G, Harvey A, Mitchell J, Milas M, Siperstein A: Comparison of laparoscopic transabdominal lateral versus posterior retroperitoneal adrenalectomy. Surgery 2009;146:621-625.
9.
Ryu DS, Park WJ, Oh TH: Retroperitoneal laparoendoscopic single-site surgery in urology: initial experience. J Endourol 2009;23:1857-1862.
10.
Hruza M, Weiss HO, Pini G, Goezen AS, Schulze M, Teber D, Rassweiler JJ: Complications in 2200 consecutive laparoscopic radical prostatectomies: standardized evaluation and analysis of learning curves. Eur Urol 2010;58:733-741.
11.
Karanikola E, Tsigris C, Kontzoglou K, Nikiteas N: Laparoscopic adrenalectomy: where do we stand now? Tohoku J Exp Med 2010;220:259-265.
12.
Prinz RA: A comparison of laparoscopic and open adrenalectomies. Arch Surg 1995;130:489-492.
13.
Filipponi S, Guerrier M, Arnaldi G, Giovagnetti M, Masini AM, Lezoche E, Mantero F: Laparoscopic adrenalectomy: a report on 50 operations. Eur J Endocrinol 1998;138:548-553.
14.
Wells SA, Merke DP, Cutler GB Jr, Norton JA, Lacroix A: Therapeutic controversy: the role of laparoscopic surgery in adrenal disease. J Clin Endocrinol Metab 1998;83:3041-3049.
15.
Al-Otaibi KM: Laparoscopic adrenalectomy: 10 years experience. Urol Ann 2012;4:94-97.
16.
Miccoli P, Materazzi G, Brauckhoff M, Ambrosini CE, Miccoli M, Dralle H: No outcome differences between a laparoscopic and retroperitoneoscopic approach in synchronous bilateral adrenal surgery. World J Surg 2011;35:2698-2702.
17.
Siperstein AE, Berber E, Engle KL, Duh QY, Clark OH: Laparoscopic posterior adrenalectomy: technical considerations. Arch Surg 2000;135:967-971.
18.
Luo Y, Chen X, Chen Z, He Y, Li N, Lai C, Xie C: Retroperitoneal laparoendoscopic single-site adrenalectomy: our initial technical experience. J Laparoendosc Adv Surg Tech A 2012;22:584-586.
19.
Liapis D, de la Taille A, Ploussard G, Robert G, Bastien L, Hoznek A, Vordos D, Abbou C, Salomon L: Analysis of complications from 600 retroperitoneoscopic procedures of the upper urinary tract during the last 10 years. World J Urol 2008;26:523-530.
20.
Salomon L, Soulie M, Mouly P, Saint F, Cicco A, Olsson E, Hoznek A, Antiphon P, Chopin D, Plante P, Abbou CC: Experience with retroperitoneal laparoscopic adrenalectomy in 115 procedures. J Urol 2001;1661:38-41.
21.
Taskin HE, Siperstein A, Mercan S, Berber E: Laparoscopic posterior retroperitoneal adrenalectomy. J Surg Oncol 2012;106:619-621.
22.
Zhang X, Shi TP, Li HZ, Ma X, Wang BJ: Laparo-endoscopic single site anatomical retroperitoneoscopic adrenalectomy using conventional instruments: initial experience and short-term outcome. J Urol 2011;185:401-406.
23.
Autorino R, Cadeddu JA, Desai MM, Gettman M, Gill IS, Kavoussi LR, Lima E, Montorsi F, Richstone L, Stolzenburg JU, Kaouk JH: Laparoendoscopic single-site and natural orifice transluminal endoscopic surgery in urology: a critical analysis of the literature. Eur Urol 2011;59:26-45.
24.
Sasaki A, Baba S, Obuchi T, Umemura A, Mizuno M, Wakabayashi G: Single-port laparoscopic adrenalectomy for a right-sided aldosterone-producing adenoma: a case report. J Med Case Rep 2012;6:208.
25.
Wang L, Liu B, Wu Z, Yang Q, Chen W, Sheng H, Xu Z, Xiao L, Wang C, Sun Y: Comparison of single-surgeon series of transperitoneal laparoendoscopic single-site surgery and standard laparoscopic adrenalectomy. Urology 2012;79:577-583.
26.
Kommu SS, Rané A: Devices for laparoendoscopic single-site surgery in urology. Expert Rev Med Devices 2009;6:95-103.
27.
Walz MK: Minimally invasive adrenal gland surgery. Transperitoneal or retroperitoneal approach? Chirurg 2012;83:536-545.
28.
Fiszer P, Toutounchi S, Pogorzelski R, Krajewska E, Cieśla W, Skórski M: Laparoscopic adrenalectomy - assessing the learning curve. Pol Przegl Chir 2012;84:293-297.
29.
Rubinstein M, Gill IS, Aron M, Kilciler M, Meraney AM, Finelli A, Moinzadeh A, Ukimura O, Desai MM, Kaouk J, Bravo E: Prospective, randomized comparison of transperitoneal versus retroperitoneal laparoscopic adrenalectomy. J Urol 2005;174:442-445.
30.
Bergamini C, Martellucci J, Tozzi F, Valeri A: Complications in laparoscopic adrenalectomy: the value of experience. Surg Endosc 2011;25:3845-3851.
31.
Poulin EC, Schlachta CM, Burpee SE, Pace KT, Mamazza J: Laparoscopic adrenalectomy: pathologic features determine outcome. Can J Surg 2003;46:340-344.
32.
Moinzadeh A, Gill IS: Laparoscopic radical adrenalectomy for malignancy in 31 patients. J Urol 2005;173:519-525.
© 2013 S. Karger AG, Basel
2013
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.